Literature DB >> 18708971

The impact of drug samples on prescribing to the uninsured.

David P Miller1, Richard J Mansfield, Jonathan B Woods, James L Wofford, William P Moran.   

Abstract

OBJECTIVE: To determine whether drug samples are associated with physicians prescribing fewer generic, less costly medications.
METHODS: We conducted a retrospective study at a large university-affiliated internal medicine practice containing over 70 physicians. Using a pharmacy database, we identified all prescriptions written to uninsured or Medicaid patients that belonged to one of four classes of chronic medications. For the 9 months before and after the clinic closed its drug sample closet, we calculated the percentage of medications prescribed as generics and the mean cost of a 30-day supply of a prescription.
RESULTS: Of 8911 prescriptions, 1973 met inclusion criteria. For uninsured patients, the percentage of medications prescribed as generics rose from 12% to 30% after the clinic closed its drug sample closet (P = 0.004). By consecutive three month periods, the percentage of prescribed generic medications rose steadily to a maximum of 40% (P < 0.001). For Medicaid patients, there was no significant change in generic prescribing (63% generic with samples versus 65% generic without samples, P = 0.42). Two factors were associated with generic prescribing in logistic regression: the absence of drug samples (OR 4.54, 95% CI 1.37-15.0) and the prescriber being an attending physician (OR 5.26, 95% CI 2.24-12.4). There was no statistically significant change in cost for either group.
CONCLUSIONS: Physicians were three times more likely to prescribe generic medications to uninsured patients after drug samples were removed from the office. Drug samples may paradoxically lead to higher costs if physicians with access to samples prescribe more brand-name only drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708971     DOI: 10.1097/SMJ.0b013e3181814d52

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  8 in total

1.  Effect of drug sample removal on prescribing in a family practice clinic.

Authors:  Daniel M Hartung; David Evans; Dean G Haxby; Dale F Kraemer; Gabriel Andeen; Lyle J Fagnan
Journal:  Ann Fam Med       Date:  2010 Sep-Oct       Impact factor: 5.166

Review 2.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  Drug samples in family medicine teaching units: a cross-sectional descriptive study: Part 2: portrait of drug sample management in Quebec.

Authors:  Andréa Lessard; Marie-Thérèse Lussier; Fatoumata Binta Diallo; Michel Labrecque; Caroline Rhéaume; Pierre Pluye; Roland Grad
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

Review 4.  Influencers of generic drug utilization: A systematic review.

Authors:  Jennifer N Howard; Ilene Harris; Gavriella Frank; Zippora Kiptanui; Jingjing Qian; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2017-08-04

5.  The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey.

Authors:  Richard G Pinckney; A Shams Helminski; Amanda G Kennedy; Charles D Maclean; Laurie Hurowitz; Elizabeth Cote
Journal:  J Gen Intern Med       Date:  2010-08-31       Impact factor: 5.128

6.  Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.

Authors:  Michael P Hurley; Randall S Stafford; Alfred T Lane
Journal:  JAMA Dermatol       Date:  2014-05       Impact factor: 10.282

7.  Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology.

Authors:  Christian Hampp; Patty Greene; Simone P Pinheiro
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

8.  The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Authors:  Heather C Worthington; Lucy Cheng; Sumit R Majumdar; Steven G Morgan; Colette B Raymond; Stephen B Soumerai; Michael R Law
Journal:  Implement Sci       Date:  2017-11-25       Impact factor: 7.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.